Clinical Trial Update: Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Acthar Gel for uveitis has completed and posted results in July 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis
• Clinically Significant Macular Edema
• Intermediate Uveitis
• Posterior Uveitis
• Scleritis
• Uveitis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Tampa Bay Uveitis Center, LLC | Conditions: Uveitis, Anterior Uveitis | Phase 4 | Status: COMPLETED | Results posted: 2018-07-02